Stable CAD (Coronary artery disease)

Latest stable coronary artery disease (stable CAD) content in interventional cardiology - research, practice, and education

A complex and changing disease state requiring wide expertise, stable CAD can involve a diverse range of underlying chronic or evolutionary stages involving full use of all available tools, devices and techniques like those for invasive imaging and functional assessment. Taking into account underlying comorbidities such as diabetes is critical. Advances in imaging techniques, as well as the use of adjunctive pharmacotherapy, vascular access or invasive interventions such as bypass surgery, are important, as are understanding bleeding risks, all of which can be found here…

Filtered By
Stable CAD

309 results

Artificial intelligence and advanced imaging in coronary interventions

19 May 2026 – From EuroPCR 2026

This session explores the integration of artificial intelligence with advanced imaging modalities in coronary interventions. Topics include quantitative myocardial blood flow assessment via co-registered CCTA and angiography, AI-guided real-time procedural support, novel video frame interpolation techniques, high-risk plaque identification through AI-derived OCT stress mapping, and validation...

Improving interventional care and occupational safety

19 May 2026 – From EuroPCR 2026

This session addresses advancements in interventional cardiology care quality and occupational safety. Key topics include patient-centered care perspectives, optimized catheterization lab scheduling, the impact of procedural volumes on outcomes, and innovations in radiation protection technologies.

How to best identify and manage vulnerable plaque?

19 May 2026 – From EuroPCR 2026

Hector Garcia-Garcia joins Salvatore Brugaletta in a discussion on the concept of vulnerable plaque, a key topic in contemporary cardiology. Together, they review the well-established definition of vulnerable plaque, characterised by high-risk features that predispose to rupture and cardiovascular events, and explore how advances in invasive and...

How to best identify and manage vulnerable plaque?

NOBLE trial: 10-year outcomes of PCI vs CABG in left main disease

13 Apr 2026

Long-term evidence comparing PCI and CABG for unprotected left main coronary disease has been limited and sometimes conflicting. The 10-year results from the NOBLE trial now provide important clarity on all-cause mortality outcomes with both revascularisation strategies.

Ruxandra Sava

Reviewer

Ruxandra Sava
PCI vs CABG in left main disease: 10-year NOBLE results

Intravascular imaging vs angiography guided complex PCI: 5-year outcomes from a randomised trial

13 Apr 2026

The RENOVATE-COMPLEX-PCI 5-year outcomes confirm the long-term durability of benefits seen with intracoronary imaging over angiography guided PCI in complex lesions.

Angela McInerney

Reviewer

Angela McInerney

Reviewer

Nieves Gonzalo
Intravascular imaging vs angiography guided complex PCI: the RENOVATE-COMPLEX-PCI 5 year outcomes

ALL-RISE: A large-scale, global randomized trial of coronary physiology derived from conventional angiography compared with an invasive pressure wire-based approach to guide PCI

28 Mar 2026

Mirvat Al Asnag provides her take on the ALL-RISE randomised trial presented by Ajay J. Kirtane at ACC.26 in New Orleans.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
A large-scale, global randomized trial of coronary physiology derived from conventional angiography compared with an invasive pressure wire-based approach to guide percutaneous coronary intervention

HOST-EXAM:10-year follow-up of clopidogrel vs aspirin monotherapy in stable CAD after PCI with drug-eluting stent

30 Mar 2026

Nicola Ryan provides her take on the 10-year follow-up of the HOST-EXAM, which was presented by Hyo-Soo Kim at ACC.26 in New Orleans.

Nicola Ryan

Author

Nicola Ryan
10-year follow-up of clopidogrel vs aspirin monotherapy in stable coronary artery disease after percutaneous coronary intervention with drug-eluting stent

Intravascular ultrasound-guided or angiography-guided complex high-risk PCI – The IVUS CHIP trial

28 Mar 2026

Daniele Giacoppo reports and provides his perspective on the main results of the IVUS-CHIP trial, presented by Roberto Diletti from the Erasmus University Medical Center, Rotterdam, the Netherlands, during a Late-Breaking Trials session at the ACC.26 in New Orleans, and simultaneously published in the New England Journal of...

Daniele Giacoppo

Author

Daniele Giacoppo
Intravascular ultrasound guidance for complex high-risk indicated procedures – The Ivus Chip trial

Coronary OCT and CMR imaging to determine sex differences in underlying causes of myocardial infarction with no obstructive coronary arteries

29 Mar 2026

Nicola Ryan provides her take on the trial evaluating multi-modality imaging to determine underlying causes of MINOCA in women and men. The trial results were presented by Harmony R. Reynolds at ACC.26 in New Orleans and simultaneously published in Circulation.

Nicola Ryan

Author

Nicola Ryan
Coronary optical coherence tomography and cardiac magnetic resonance imaging to determine sex differences in underlying causes of myocardial infarction with no obstructive coronary arteries

A prospective multicenter registry to define coronary vasomotor disorders in ischemia with nonobstructive coronary arteries: Primary results of DISCOVER INOCA

28 Mar 2026

Aaysha Cader interviews Samit M. Shah, who presented the primary results of the DISCOVER INOCA registry at ACC.26. 

Author

Aaysha Cader
Samit Shah

Author

Samit Shah
A prospective multicenter registry to define coronary vasomotor disorders in ischemia with nonobstructive coronary arteries: Primary results of DISCOVER INOCA